Celemics, Inc.

Founded in 2010, Celemics leads innovation in the Next Generation Sequencing field with advanced enzymes, reagents, probes, and bioinformatics solutions, providing exceptional quality with ISO-certified standards. With headquartered in Seoul and offices in the U.S. and India, we proudly serve customers across over 54 countries. Celemics provides optimized NGS solutions that drive new insights across various fields. Our offerings include Library Preparation Kits, NGS Target Enrichment Panels, Bioinformatics Analysis, and NGS Services. These solutions support key areas, including Laboratory Developed Tests (LDTs), Clinical Research, Viral & Pathogen Research, Agrigenomics, Drug Development, and more. Our major clients include Hospitals and Clinical Laboratories, Government and Research Institutions, Agricultural Institutions, as well as Biopharma, CROs, and Biotech Companies, highlighting our wide-reaching impact in advancing research.